Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1487-1492

  Peng, Cheng Yuan ^a   Tsai, Sun Lung ^a   Yeh, Chau Ting ^a   Hung, Shao Pi ^a   Chen, Miin Fu ^a   Chen, Tse Ching ^a   Chu, Chia Ming ^a   Liaw, Yun Fan ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chromosome 1p36; Hepatocellular carcinoma; Loss of heterozygosity; p73; Tumor suppressor gene

Indexed keywords

LIVER PROTEIN; PROTEIN P53; PROTEIN P73;

ADULT; AGED; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1P; CLINICAL ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DNA MODIFICATION; FEMALE; FRAMESHIFT MUTATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0033868039     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Okuda K: Hepatocellular carcinoma: recent progress. Hepatology 15; 948-963, 1992.
2. Robinson WS: Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu Rev Med 45: 297-323, 1994.
3. Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC and Chen DS: Frequent genetic alternations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 54: 4188-4192, 1994.
4. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T and Nakamura Y: Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosome Cancer 13: 163-167, 1995.
5. Harris CC and Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318-1327, 1993.
6. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
7. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, Mckeon F and Caput D: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819, 1997.
8. Jost CA, Marin MC and Kaelin WGJr: p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194, 1997.
9. Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L. Voute PA, Westerveld A, Slater R, Delattre O and Versteeg R: Evidence for two tumor suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 4: 535-539, 1995.
10. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE and Kefford RF: Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86: 4614-4618, 1989.
11. Praml C, Finke LH, Herfarth C, Schlag P, Schwab M and Amler L: Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 11: 1357-1362, 1995.
12. Genuardi M, Tsihira H, Anderson DE and Saunders GF: Distal deletion of chromosome 1p in ductal carcinoma of the breast. Am J Hum Genet 45: 73-82, 1989.
13. Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI and Liu W: Activation of p73 silent allele in lung cancer. Cancer Res 58: 2347-2349, 1998.
14. Nimura Y, Mihara M, Ichimiya S. Sakiyama S, Seki N, Ohira M, Nomura N, Fujimori M, Adachi W, Amano J, He M, Ping YM and Nakagawara A: p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer 78: 437-440, 1998.
15. Mai M, Huang H, Reed C, Qian C, Smith JS, Alderete B, Jenkins R, Smith DI and Liu W: Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1p-arm deletions. Genomics 51: 359-363, 1998.
16. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi T and Takahashi T: Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 58: 1380-1383, 1998.
17. Takahashi H, Ichimiya S, Nimura Y, Watanabe M, Furusato M, Wakui S, Yatani R, Aizawa S and Nakagawara A: Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res 58: 2076-2077, 1998.
18. Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C. Smith Dl and Liu W: Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 17: 1739-1741, 1998.
19. Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D and Nakagawara A: p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18: 1061-1066, 1999.
20. Mihara M, Nimura Y, Ichimiya S, Sakiyama S, Kajikawa S, Adachi W, Amano J and Nakagawara A: Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma. Br J Cancer 79: 164-167, 1999.
21. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, Mossner J, Engeland K and Wittekind C: Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 91: 1154-1158, 1999.
22. Schittek B, Sauer B and Garbe C: Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines, Int J Cancer 82: 583-586, 1999.
23. Yokozaki H, Shitara Y, Fujimoto JY, Hiyama T, Yasui W and Tahara E: Alternations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype. Int J Cancer 83: 192-196, 1999.
24. Shishikura T, Ichimiya S, Ozaki T, Nimura Y, Kageyama H, Nakamura Y, Sakiyama S, Miyauchi M, Yamamoto N, Suzuki M, Nakajima N and Nakagawara A: Mutational analysis of the p73 gene in human breast cancers. Int J Cancer 84: 321-325, 1999.
25. Stirewalt DL, Clurman B, Appelbaum FR, Willman CL and Radich JP: p73 mutations and expression in adult de novo acute myelogenous leukemia. Leukemia 13: 985-990, 1999.
26. Kawano S, Miller CW, Gombart AF, Bartram CR, Matsuo Y, Asou H, Sakashita A, Said J, Tatsumi E and Koeffler: Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood 94: 1113-1120, 1999.
27. Han S, Semba S, Abe T, Makino N, Furukawa T, Fukushige S, Takahashi H, Sakurada A, Sato M, Shiiba K, Matsuno S, Nimura Y, Nakagawara A and Horii A: Infrequent somatic mutations of the p73 gene in various human cancers. Eur J Surg Oncol 25: 194-198, 1999.
28. Yoshikawa H, Nagashima M, Khan MA, McMenamin MG. Hagiwara K and Harris CC: Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene 18: 3415-3421, 1999.
29. Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D, and Kaelin WGJr: Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Biol 18: 6316-6324, 1998.
30. Kaelin WGJr: Another p53 doppelganger. Science 281: 57-58, 1998.
31. Gong J, Costanzo A, Yang HQ, Melino G, Kaelin WGJr, Levrero M and Wang JYJ: The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806-809. 1999.
32. Knudson AGJr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823, 1971.